Detalhe da pesquisa
1.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Nature
; 601(7891): 110-117, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758478
2.
Behçet's patients' response to COVID-19 vaccination.
Clin Immunol
; 255: 109700, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482118
3.
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.
J Infect Dis
; 226(11): 1903-1908, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906930
4.
Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease.
Clin Infect Dis
; 75(11): 2016-2018, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616095
5.
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Immunology
; 166(1): 68-77, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156709
6.
Interferon epsilon promotes HIV restriction at multiple steps of viral replication.
Immunol Cell Biol
; 95(5): 478-483, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28045025
7.
Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
Lancet
; 396(10260): 1394-1395, 2020 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129388
8.
CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants.
J Gen Virol
; 96(Pt 7): 1899-905, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762593
9.
Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses.
Retrovirology
; 11: 3, 2014 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24410916
10.
Influence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination.
NPJ Vaccines
; 9(1): 87, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38778017
11.
Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1.
bioRxiv
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370662
12.
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Lancet Rheumatol
; 6(2): e92-e104, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267107
13.
Curbside particulate matter and susceptibility to SARS-CoV-2 infection.
J Allergy Clin Immunol Glob
; 2(4): 100141, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781647
14.
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Nat Commun
; 14(1): 5139, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612310
15.
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
iScience
; 26(6): 106937, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275518
16.
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial.
Nutrients
; 14(18)2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145196
17.
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response.
Cell Rep Methods
; 2(9): 100279, 2022 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975199
18.
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
Science
; 375(6577): 183-192, 2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855510
19.
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
Cell Rep Med
; 3(3): 100557, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474751
20.
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
Science
; 377(6603): eabq1841, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699621